Current price
$0.00
0.0% today
Bearish
38
+0 vs yesterday
Last updated: 8 hr ago
Pfizer faces near-term headwinds as BioNTech trial failure and institutional selling outweigh neutral vaccine approval catalysts.
Kingsview Wealth Management LLC acquired a new position in Pfizer Inc. (NYSE:PFE – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. T
Open source ↗Capital Advisors Inc. OK lowered its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 2.9% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. Th
Open source ↗Pfizer Inc. (NYSE:PFE – Get Free Report)’s share price fell 1% during trading on Thursday . The company traded as low as $27.83 and last traded at $28.0050. 29,931,103 shares traded hands during mid-d
Open source ↗Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc., Abbott Laboratories, AbbVie, Pfizer, and Gilead Sciences are the seven Pharmaceutical stocks to watch today, according to MarketBeat’s stoc
Open source ↗Capital Advisors Inc. OK lowered its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 2.9% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. Th
Open source ↗Mid-Morning Look Friday, August 28, 2026 Index Up/Down % Last DJ Industrials -66.72 0.12% 53,502 S&P 500 -5.71 0.07% 7,724 Nasdaq -36.68 0.14% 26,505 Russell 2000 -19.17 0.64% 2,995 U.S. stocks opened
Open source ↗